ABSTRACT The current study evaluated the effect of subchronic toxicity of Ganoderma lucidum Polysaccharides peptide (PsP) to liver physiology and histopatology in rats. The 80 rats were randomly divided into four groups male and four groups female (10 rats per group): Three PsP treated group: 300, 600, 1200 mg/KgBW, and one normal control group. Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and Alkaline phosphate (ALP) levels of rats were measured, and histopathology changes: the average of cloudy degeneration, ballooning degenaration, the number of kupfer cell, inflamation cell and necrotizing cell were examinated, after 90 days of treatment with Ganoderma lucidum PsP, the ANOVA test show that AST, ALT and ALP levels of ...
AIM: To study the protective effects of Ganoderma lucidum polysaccharides peptide (GLPP) on the mice...
The aim of the current study was to elucidate the potential therapeutic effect of Ganoderma lucidum ...
ObjectiveObstructive jaundice develops after occlusion of the common bile duct. Direct hyperbilirubi...
Background and Aim: Natural products are currently widely used as alternative treatments for liver d...
Introduction:Ganoderma Lucidum was reported contained several such aspolysaccharides, triterpenes, s...
The purpose of the present study was to investigate the effect of Ganoderma lucidum polysaccharide (...
Background. The liver is one of the most commonly affected organs in multiple organ dysfunction synd...
AIM: To examine the effect of ganoderma lucidum polysaccharide (GLP) on the immune liver injury indu...
To examine the effect of ganoderma lucidum polysaccharide (GLP) on the immune liver injury induced b...
Pharmacology & PharmacyPhysiologySCI(E)CPCI-S(ISTP)0MEETING ABSTRACT11A230-A2303
Ganoderma lucidum is known as a medicine food homology that can ameliorate gastrointestinal diseases...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
Ganoderma lucidum mushroom (also known as Ling Zhi in China, Mannetake /Reishi in Japan) has been wi...
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) encompasses a series of pathologic change...
Obstructive jaundice develops after occlusion of the common bile duct. Direct hyperbilirubinaemia, w...
AIM: To study the protective effects of Ganoderma lucidum polysaccharides peptide (GLPP) on the mice...
The aim of the current study was to elucidate the potential therapeutic effect of Ganoderma lucidum ...
ObjectiveObstructive jaundice develops after occlusion of the common bile duct. Direct hyperbilirubi...
Background and Aim: Natural products are currently widely used as alternative treatments for liver d...
Introduction:Ganoderma Lucidum was reported contained several such aspolysaccharides, triterpenes, s...
The purpose of the present study was to investigate the effect of Ganoderma lucidum polysaccharide (...
Background. The liver is one of the most commonly affected organs in multiple organ dysfunction synd...
AIM: To examine the effect of ganoderma lucidum polysaccharide (GLP) on the immune liver injury indu...
To examine the effect of ganoderma lucidum polysaccharide (GLP) on the immune liver injury induced b...
Pharmacology & PharmacyPhysiologySCI(E)CPCI-S(ISTP)0MEETING ABSTRACT11A230-A2303
Ganoderma lucidum is known as a medicine food homology that can ameliorate gastrointestinal diseases...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
Ganoderma lucidum mushroom (also known as Ling Zhi in China, Mannetake /Reishi in Japan) has been wi...
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) encompasses a series of pathologic change...
Obstructive jaundice develops after occlusion of the common bile duct. Direct hyperbilirubinaemia, w...
AIM: To study the protective effects of Ganoderma lucidum polysaccharides peptide (GLPP) on the mice...
The aim of the current study was to elucidate the potential therapeutic effect of Ganoderma lucidum ...
ObjectiveObstructive jaundice develops after occlusion of the common bile duct. Direct hyperbilirubi...